NIFTY Pharma jumps over 3% on India–US trade deal boost; Cipla, Sun Pharma, Dr Reddy’s lead gains
The NIFTY Pharma index delivered a strong breakout session, rising over 3 percent as investors cheered positive developments from the India–US trade deal discussions. The rally was broad based, with heavyweights like Cipla, Sun Pharma, and Dr Reddy’s Laboratories leading from the front, while mid cap names such as Lupin and Biocon also posted solid gains.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
